Skip to content

ACRO BIOMEDICAL CO., LTD.

ACBM

CIK 0001622996

← back to feed
Revenue (TTM)
$0
Q1 Apr 2026
Net Income (TTM)
−$187.45K
−139.1% YoY Q1 Apr 2026
EPS Diluted (TTM)
$0.00
Q1 Apr 2026
Gross Margin
—
Q1 Apr 2026
Operating Margin
—
Q1 Apr 2026
Net Margin
—
Q1 Apr 2026
Free Cash Flow (TTM)
—
Q1 Apr 2026
Cash
$215.49K
Q1 Apr 2026
Total Debt
—
Q1 Apr 2026
Shares Outstanding
60.04M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings